Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.340
-0.030 (-2.19%)
Apr 29, 2026, 11:51 AM EDT - Market open
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
42
Market Cap
113.43M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verrica Pharmaceuticals | 35.58M |
| Seer, Inc. | 16.58M |
| Cibus | 3.64M |
| Cardiff Oncology | 593.00K |
| NeOnc Technologies Holdings | 39.99K |
| InflaRx | 34.44K |
| Genelux | 8.00K |
VANI News
- 4 weeks ago - Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 - GlobeNewsWire
- 3 months ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 3 months ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 5 months ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Vivani Medical Transcript: 2025 ThinkEquity Conference - Transcripts
- 7 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 7 months ago - Vivani Medical Transcript: Emerging Growth Conference 2025 - Transcripts